Hearing Aid Pediatric denied for failing step therapy by Aetna?

Aetna's specific coverage criteria for hearing aid pediatric are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why This Denial Happens

Aetna occasionally applies a step-therapy framework to pediatric hearing aids, requiring documentation that less costly or lower-technology devices have been tried before approving the requested model. This denial can also appear when a child is moving from an entry-level device to one with features — such as directional microphones, Bluetooth connectivity, or rechargeable batteries — that the plan classifies as a higher tier. Because hearing aids for children are medical devices, not interchangeable drugs, step-therapy logic is frequently contested in appeal.

## Why This Is Appealable

Step-therapy for medically necessary durable medical equipment (DME) is highly appealable when the prescribing audiologist documents that a lower-technology device is clinically inadequate for the child's specific hearing loss profile, listening environment, or developmental stage. Many states have passed step-therapy reform laws requiring insurers to grant exceptions when the required prior step has already failed, is contraindicated, or is otherwise clinically inappropriate. Check whether your state has such a law; it may dramatically shorten the appeals process.

## Federal Appeal Framework

• Internal appeal: File within the deadline on your denial letter. For standard reviews Aetna must respond within 30 days; urgent cases are faster.
• External review (ACA §2719): After exhausting internal appeals, you may request independent external review — generally within four months of final denial. The reviewer is an independent organization, not Aetna.
• Expedited review: Available if the step-therapy delay would harm the child's hearing development, language acquisition, or safety.
• ERISA §503: Applies to self-funded employer plans; full-and-fair review is required, with federal court as the backstop after exhaustion.

## Documentation to Gather

1. Audiologist's clinical justification — a detailed letter explaining why the requested device tier is necessary given the child's degree and configuration of hearing loss, and why a lower-tier device would be clinically inadequate. 2. Prior device trial records — if a lower-tier device was already tried, include fitting dates, trial period, and outcome notes documenting its failure or inadequacy. 3. Developmental and educational impact — speech-language pathology records, school evaluations, or teacher/therapist letters showing how device features affect the child's access to sound and language development. 4. Aetna's step-therapy exception criteria — obtained from the denial notice or Aetna's published policy — and a point-by-point response showing each exception criterion is met. 5. Relevant clinical guidelines — a reference to the applicable AAO-HNS or AAA guideline organization's position on pediatric amplification standards (without quoting specific numbers).

## Criteria-Mapping Structure

Obtain Aetna's step-therapy exception criteria from the denial notice and its published medical policy. Build a two-column table listing each criterion in the left column and the supporting clinical fact in the right column. If the policy permits bypass when the step-therapy alternative is clinically inappropriate for the patient's age or hearing profile, document that explicitly with the audiologist's language. Attaching signed audiologist notes and any prior device trial records as labeled exhibits will make the record self-contained and difficult to deny on procedural grounds.